Evaluation of the immunotropic activity of an immunomodulatory drug in cats with generalized dermatophytosis
Ukrainian Journal of Veterinary and Agricultural Sciences · 04.07.2026 · 9 (3) · 62-68
DOI: 10.32718/ujvas9-3.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ukrainian Journal of Veterinary and Agricultural Sciences, online erschienen am 04.07.2026. Verfasst von P. M. Bezditnyi und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dermatophytosis in cats is a common zoonotic fungal disease that frequently progresses to a generalized form in animals with secondary immunodeficiency. Cell-mediated immunity, particularly T lymphocytes, plays a pivotal role in antifungal defense. The aim of this study was to evaluate the immunotropic activity of the complex immunomodulator Zhyttiedar (containing 10% transfer factor) in cats with generalized dermatophytosis and to compare its therapeutic efficacy with that of Imunofan. Fifteen cats aged 6–18 months were included in the study and allocated into three groups (n = 5 per group): Group I – clinically healthy cats (control); Group II – cats with generalized dermatophytosis treated subcutaneously with Zhyttiedar at a dose of 0.5 cm³/kg on days 1, 4, and 8; and Group III – infected cats treated with Imunofan. All animals additionally received topical antiseptic treatment. At the beginning of the study, diseased cats exhibited marked immunodeficiency, characterized by reductions in leukocyte count (32 %), lymphocyte count (38 %), and T-lymphocyte count (47 %), accompanied by a pronounced increase in C-reactive protein (118-fold), interleukin-1 (IL-1), and interleukin-6 (IL-6). Administration of Zhyttiedar induced positive changes in immune parameters as early as day 3 of treatment. By day 8, T-cell immunity had recovered, phagocytic activity had normalized, and inflammatory responses had markedly decreased. On day 14, cellular immune parameters exceeded those of the healthy control group, while mycological cultures were negative in 4 of 5 cats. Complete clinical recovery occurred between days 16 and 22. In contrast, cats treated with Imunofan exhibited a considerably weaker immunological response, predominantly involving humoral immunity. Fungal persistence was observed, and clinical recovery was 1.8–2.2 times slower, requiring 36–48 days. One month after treatment, cats receiving Zhyttiedar maintained persistently elevated cellular immunity without evidence of chronic inflammation, whereas such effects were not observed in the comparison group. Zhyttiedar exhibits pronounced immunotropic activity by effectively stimulating cell-mediated immunity. Compared with Imunofan, it more rapidly normalizes hematological and immunological parameters and provides substantially greater therapeutic efficacy in cats with generalized dermatophytosis.
Zitieren
APA
Bezditnyi, P. M., Kovalenko, V. L., Romanko, M. Y., Babkina, M. M., Kulykova, V. V., & Marchenko, T. V. (2026). Evaluation of the immunotropic activity of an immunomodulatory drug in cats with generalized dermatophytosis. Ukrainian Journal of Veterinary and Agricultural Sciences, 9(3), 62-68. https://doi.org/10.32718/ujvas9-3.09
Vancouver
Bezditnyi PM, Kovalenko VL, Romanko MY, Babkina MM, Kulykova VV, Marchenko TV. Evaluation of the immunotropic activity of an immunomodulatory drug in cats with generalized dermatophytosis. Ukrainian Journal of Veterinary and Agricultural Sciences. 2026;9(3):62-68. doi:10.32718/ujvas9-3.09
BibTeX
@article{Bezditnyi2026,
author = {Bezditnyi, P. M. and Kovalenko, V. L. and Romanko, M. Ye. and Babkina, M. M. and Kulykova, V. V. and Marchenko, T. V.},
title = {Evaluation of the immunotropic activity of an immunomodulatory drug in cats with generalized dermatophytosis},
journal = {Ukrainian Journal of Veterinary and Agricultural Sciences},
year = {2026},
volume = {9},
number = {3},
pages = {62--68},
doi = {10.32718/ujvas9-3.09}
}
EUVIMED